Healthcare's Provider Data Challenges
ProviderTrust highlights several factors responsible for undermining data integrity between providers and payers.| info.medcitynews.com
ProviderTrust highlights several factors responsible for undermining data integrity between providers and payers.| info.medcitynews.com
As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to review and potentially approve such treatments.| MedCity News
presented by | MedCity News
